Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
4-Phenyl-1h-imidazole is a small molecule compound with the chemical formula C9H8N2 and a molecular weight of approximately 144.17. It consists of an imidazole ring substituted at the fourth position with a phenyl group. This compound is primarily used as a biochemical reagent in research settings and has been studied for its interactions with proteins such as cytochrome P450 enzymes[3][8]. There are no approved therapeutic indications or clinical uses for this molecule; it is considered experimental and not approved by regulatory agencies for medical use[1][3]. Its mechanism of action in biological systems is not well characterized.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 4-phenyl-1h-imidazole.